According to analysis by Future Market Insights (FMI), the global axillary hyperhidrosis treatment market was valued at USD 1.6 billion in 2022 and is expected to reach approximately USD 3.3 billion ...

Excessive sweating is a very common problem, and there are many treatments you can try yourself or discuss with your doctor.

The main indication for these products is as a first-line treatment for mild axillary hyperhidrosis. Oral anticholinergic agents such as glycopyrrolate or amitriptyline represent the main systemic ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children 9 years of age and older.

The U.S. Food and Drug Administration empowered Botox 2004 to treat axillary hyperhidrosis (severe underarm sweating) for ...

Botanix Pharmaceuticals Limited (AU:BOT) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by ...

Ecclock for the treatment of primary axillary hyperhidrosis; Regroth, a periodontal regenerative agent; Hernicore for the treatment of lumbar disc herniation; and Seprafilm, an adhesion barrier ...